Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
3.
Heart Lung ; 50(2): 292-295, 2021.
Artículo en Inglés | MEDLINE | ID: covidwho-1065104

RESUMEN

The COVID 19 pandemic resulted in a total reduction in the number of hospitalizations for acute coronary syndromes. A consequence of the delay in coronary revascularization has been the resurgence of structural complications of myocardial infarctions. Ventricular septal rupture (VSR) complicating late presenting acute myocardial infarction (AMI) is associated with high mortality despite advances in both surgical repair and perioperative management. Current data suggests a declining mortality with delay in VSR repair; however, these patients may develop cardiogenic shock while waiting for surgery. Available options are limited for patients with VSR who develop right ventricular failure and cardiogenic shock. The survival rate is very low in patients with cardiogenic shock undergoing surgical or percutaneous VSR repair. In this study we present two late presenting ST elevation MI patients who were complicated by rapidly declining hemodynamics and impending organ failure. Both patients were bridged with venoarterial extracorporeal membrane oxygenation (ECMO) to cardiac transplant.


Asunto(s)
COVID-19 , Infarto del Miocardio con Elevación del ST , Rotura Septal Ventricular , Humanos , Pandemias , SARS-CoV-2 , Infarto del Miocardio con Elevación del ST/complicaciones , Infarto del Miocardio con Elevación del ST/cirugía , Choque Cardiogénico/etiología , Resultado del Tratamiento , Rotura Septal Ventricular/diagnóstico , Rotura Septal Ventricular/epidemiología , Rotura Septal Ventricular/etiología
5.
J Community Hosp Intern Med Perspect ; 10(6): 521-522, 2020 Oct 29.
Artículo en Inglés | MEDLINE | ID: covidwho-900303

RESUMEN

Although respiratory symptoms are the dominant features of COVID-19 infection, myocardial injury has been described in these patients. Reported cardiac manifestations of COVID-19 infection include myocarditis, arrhythmia and acute coronary syndrome including ST elevation myocardial infarction (STEMI). STEMI is a medical emergency and timely intervention is of utmost importance to prevent mortality and long-term morbidities. In this report, we present a wide spectrum of clinical presentations, management, and outcomes for five patients with COVID-19 infection and ST elevation on ECG.

6.
Catheter Cardiovasc Interv ; 96(3): 659-663, 2020 09 01.
Artículo en Inglés | MEDLINE | ID: covidwho-806095

RESUMEN

The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment, as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos/estadística & datos numéricos , Infecciones por Coronavirus/epidemiología , Cardiopatías/cirugía , Pandemias/estadística & datos numéricos , Neumonía Viral/epidemiología , Guías de Práctica Clínica como Asunto , Triaje/normas , COVID-19 , Procedimientos Quirúrgicos Cardíacos/métodos , Cardiología/métodos , Cardiología/normas , Infecciones por Coronavirus/prevención & control , Infección Hospitalaria/prevención & control , Femenino , Cardiopatías/diagnóstico por imagen , Humanos , Masculino , Salud Laboral/estadística & datos numéricos , Pandemias/prevención & control , Seguridad del Paciente , Neumonía Viral/prevención & control , Sociedades Médicas , Triaje/estadística & datos numéricos , Estados Unidos
7.
JACC Cardiovasc Interv ; 13(12): 1484-1488, 2020 06 22.
Artículo en Inglés | MEDLINE | ID: covidwho-598690

RESUMEN

The coronavirus disease-2019 (COVID-19) pandemic has strained health care resources around the world, causing many institutions to curtail or stop elective procedures. This has resulted in an inability to care for patients with valvular and structural heart disease in a timely fashion, potentially placing these patients at increased risk for adverse cardiovascular complications, including CHF and death. The effective triage of these patients has become challenging in the current environment as clinicians have had to weigh the risk of bringing susceptible patients into the hospital environment during the COVID-19 pandemic against the risk of delaying a needed procedure. In this document, the authors suggest guidelines for how to triage patients in need of structural heart disease interventions and provide a framework for how to decide when it may be appropriate to proceed with intervention despite the ongoing pandemic. In particular, the authors address the triage of patients in need of transcatheter aortic valve replacement and percutaneous mitral valve repair. The authors also address procedural issues and considerations for the function of structural heart disease teams during the COVID-19 pandemic.


Asunto(s)
Betacoronavirus , Procedimientos Quirúrgicos Cardiovasculares , Infecciones por Coronavirus/epidemiología , Cardiopatías/cirugía , Selección de Paciente , Neumonía Viral/epidemiología , Triaje , Procedimientos Quirúrgicos Ambulatorios , COVID-19 , Infecciones por Coronavirus/prevención & control , Infecciones por Coronavirus/transmisión , Humanos , Pandemias/prevención & control , Neumonía Viral/prevención & control , Neumonía Viral/transmisión , Derivación y Consulta , SARS-CoV-2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA